SCHEMBL2178351

SCHEMBL2178351

CNC(=O)COC(=O)N1CCN(CCCc2ccc(-c3cccc(Cl)c3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.52
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HRH1 P35367 3/20 0.46
HRH2 P25021 2/20 0.46
SIGMAR1 Q99720 4/20 0.46
HTR2A P28223 2/20 0.46
OPRM1 P35372 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
HTR7 P34969 1/20 0.46
KCNH2 Q12809 1/20 0.45
HTR1A P08908 1/20 0.44
DRD4 P21917 1/20 0.44
MCHR1 Q99705 1/20 0.43
AVPR1B P47901 2/20 0.42
MGLL Q99685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2175549 0.93 MEN1 (0.48) FAAHMEN1KMT2AHRH1HRH2
SCHEMBL2175871 0.91 FAAH (0.52) FAAHMEN1KMT2AHRH1HRH2
SCHEMBL2178407 0.90 FAAH (0.62) FAAHKMT2AHRH1HRH2SIGMAR1
SCHEMBL2177424 0.89 SIGMAR1 (0.56) FAAHHRH1SIGMAR1HTR2AOPRM1
SCHEMBL2177149 0.86 SIGMAR1 (0.51) FAAHHRH1HRH2SIGMAR1HTR2A
SCHEMBL2175558 0.86 FAAH (0.50) FAAHMEN1KMT2AHRH1HRH2
SCHEMBL2176110 0.84 HRH2 (0.53) FAAHKMT2AHRH1HRH2SIGMAR1
SCHEMBL2179130 0.84 FAAH (0.65) FAAHKMT2AHRH1HRH2SIGMAR1
SCHEMBL2175738 0.83 FAAH (0.52) FAAHMEN1KMT2AHRH1SIGMAR1
SCHEMBL2178312 0.81 SIGMAR1 (0.54) FAAHHRH1HRH2SIGMAR1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720848-B1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE- CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2007-12-05 EP claimed
US-7973042-B2 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors SANOFI-AVENTIS (FR) 2011-07-05 US disclosed
US-20090143365-A1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE-CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2009-06-04 US disclosed
US-7482346-B2 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors SANOFI-AVENTIS (FR) 2009-01-27 US disclosed
US-20070027141-A1 DERIVATIVES OF ALKYLPIPERAZINE AND ALKYLHOMOPIPERAZINE-CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143365-A1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE-CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885MEN1 4190/4885KMT2A 2247/4885
US-20070027141-A1 DERIVATIVES OF ALKYLPIPERAZINE AND ALKYLHOMOPIPERAZINE-CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885MEN1 4326/4885KMT2A 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.